Jordan Chan
@jordansfchan
PhD Candidate @JussherLab @UAlberta - Faculty of Pharmacy and Pharmaceutical Sciences
ID: 1511880754208288769
07-04-2022 01:37:45
77 Tweet
97 Takipçi
167 Takip Edilen
Grateful to have the opportunity of showing off another cover done by myself! Thanks to the editors of Circulation Research #ScienceVisualization
👏Following on in the Monday 9/09 am session will be University of Alberta Professor and Canadian Research Chair in Pharmacotherapy of Energy Metabolism in Diabetes, Dr. John Usser. Looking forward to hearing John R. Ussher’s expertise on #ketones, #insulinresistance and #GLP1 👏
ICYMI: New article by John R. Ussher Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy pubmed.ncbi.nlm.nih.gov/39093701/ UAlberta Pharmacy
Kudos to John R. Ussher & Jordan Chan for latest review paper, Incretin-mediated control of cardiac energy metabolism pubmed.ncbi.nlm.nih.gov/39013412/ UAlberta Pharmacy
Read the latest review in the #Incretins Special Collection: 📍 Incretin-mediated control of cardiac energy metabolism By Jordan Chan, Tanin Shafaati and John R. Ussher UAlberta Pharmacy 👉 ow.ly/e4sx50SXq5X
🥇🎉🥇 Congratulations to John R. Ussher, the winner of our 2024 #MidCareerResearcher prize! Ussher's review will focus on the Multifaceted Roles of Ketones in Physiology!
🎉Excited to share our new review Molecular and Cellular Biochemistry discussing how energy metabolism controls the inflammatory responses and functional phenotypes of #Macrophage in #Cardiometabolic_Diseases #Obesity #Diabetes #Atherosclerosis #HFrEF #HFpEF BioMedMUN Faculty of Medicine rdcu.be/dSiVI
It’s been an incredible journey completing my PhD at John R. Ussher . Excited to start my postdoc at Greg_Steinberg lab! I wasn’t expecting this but I’m honored to receive #CIHR Postdoctoral Fellowship. Thanks to CIHR for this opportunity. Looking forward to the new chapter
New anti-obesity drug shows promise in preventing heart failure related to Type 2 diabetes. John Ussher finds experimental weight loss drug GDF15 improves heart function in mice with diabetes, independent of its weight loss effects. John R. Ussher ualberta.ca/en/folio/2024/…
Here it is proposed that halofuginone, a FDA–approved anti-scleroderma and antiprotozoal drug, is a promising anti-#obesity agent acting via FGF-21 and GDF-15 in preclinical mouse and pig models Science Advances #weightloss science.org/doi/10.1126/sc…
Grateful to John R. Ussher Jordan SF Chan & American Diabetes Association for featuring our T2D cardiomyopathy model in their editorial.Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals diabetesjournals.org/diabetes/artic… William Harvey Research Institute Wellcome
Thank you to ISHR International ECI Committee Qutuba G Karwi for giving me the opportunity to present some of my research at the #ISHR2025 ECI Symposium today in Nara, Japan!!
Same spot, 3 days later, after an amazing conference and…a best ECI presentation award! Thank you again ISHR2025 in Nara Qutuba G Karwi for the opportunity to present some of my research in the John R. Ussher. Had a great time reconnecting with old colleagues and getting to meet some new ones!
🚨New from our group in Circulation Research We identify a FoxO1-zDHHC4-CD36 S-acylation axis driving metabolic + contractile dysfunction in the diabetic heart. Blocking this pathway reprograms FA metabolism and improves heart function. Read more: 🔗 ahajournals.org/doi/full/10.11…
RESEARCH | Logan Townsend, Greg_Steinberg et. al. (@MacMODR) #Anxiety -like behaviour in mice, as a result of psychological #stress, is shown to be mediated by #GDF15 release in response to adipose tissue #lipolysis 🐭 nature.com/articles/s4225…
Kaitlyn Dennis et al found #FoxO1-zDHHC4-#CD36 S-acylation axis drives metabolic dysfunction in #diabetes. Learn more at ahajrnls.org/3Zpvc0g @heatherlab.bsky.social Heather John R. Ussher Will Fuller Dunja Aksentijevic Ricciarelli Marcos Castro Guarda @ujangpurnama
